Piramal Enterprises’ Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), is planning to expand its Aurora facility in Canada with the addition of a new state-of-the-art wing dedicated to manufacturing Active Pharmaceutical Ingredients (APIs). A total investment of around CAD $25 million will be infused towards this expansion.
Piramal Pharma Solutions’ (PPS) Aurora facility will enhance its offerings to customers with this new addition that features around 10,500 sq. ft. of new manufacturing space. The additional capacity will cater to increasing customer demand as well as support the facility’s ability to provide APIs and HPAPIs down to an Occupational Exposure Limit (OEL) of 1mcg/m. It will also include filtration and drying capabilities that will enhance service offerings at Piramal Pharma Solutions’ Aurora facility.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
